2026 Global Healthcare Summit | Gao Yongwen: From Scale to Value Healthcare, System Reform Enters Deepwater Zone

On August 7-8, the "2026 Global Healthcare Summit" jointly organized by Hong Kong Investment Management Limited and New Frontier Group was held at the Hong Kong Convention and Exhibition Centre. Dr. Gao Yongwen, Executive Member of the National Committee of the Chinese People's Political Consultative Conference, Non official Member of the Hong Kong Executive Council, former Director of the Hong Kong Food and Health Bureau, and Chairman of the conference, delivered a speech at the "Frontier Insights: Reshaping Medical Industry Innovation" session. Gao Yongwen stated that this year marks the beginning of the national "15th Five Year Plan", and the high-quality development of healthcare is not only about technological progress, but also about reshaping a value based integrated healthcare system to achieve population health outcomes that are commensurate with the "Healthy China 2035" goal. He pointed out that Hong Kong, with its dual track system of public and private sectors, has long been renowned internationally for having the highest life expectancy in the world and a moderate proportion of healthcare expenditure to GDP. However, like many developed economies, it faces the challenge of population aging. To this end, Hong Kong is promoting a paradigm shift from "healthcare" to "health", with primary healthcare as the cornerstone, integrating disease prevention, health assessment, chronic disease management, and cross disciplinary care into a seamless community system through regional health centers, family doctor models, primary healthcare departments, and "co treatment networks". He emphasized that "health does not start when people become patients, but should run through the entire life cycle." At the same time, Hong Kong, with the advantage of "one country, two systems," relying on world-class scientific research capabilities, international regulatory standards, and active capital markets, is accelerating the construction of a linkage ecosystem between scientific research, clinical practice, and advanced manufacturing. With the establishment of the Northern Metropolitan Area and the Hong Kong Centre for the Regulation of Medicines and Medical Devices (CMPR).

EEO www.eeo.news

Address: RM 20 UNIT B3, 07/FL TUEN MUN IND CTR NO 2 SAN PING CIRCUIT TUEN MUN HONG KONG

Copyright @ Economic Observer Network 2001-2025